We are live on
!
Find out more
Syndax Pharmaceuticals
SNDX
SNDX
142 hedge funds and large institutions have $1.03B invested in Syndax Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 50 increasing their positions, 24 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 11
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
144% more call options, than puts
Call options by funds: $8.49M | Put options by funds: $3.48M
110% more capital invested
Capital invested by funds: $493M → $1.03B (+$541M)
108% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 24
43% more funds holding
Funds holding: 99 → 142 (+43)
11.63% more ownership
Funds ownership: 88.81% → 100.43% (+12%)
Holders
142
Holders Change
+43
Holders Change %
+43.43%
% of All Funds
2.51%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.09%
New
55
Increased
50
Reduced
24
Closed
11
Calls
$8.49M
Puts
$3.48M
Net Calls
+$5.01M
Net Calls Change
+$5.13M
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$32.1M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$30.2M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$25.9M |
| 4 |
HM
HealthCor Management
New York
|
+$21.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20.3M |
